Your Collaborative Forum to Shape the Future of Dermatology
The Dermatology Drug Development Summit Europe returns for its 6th year as the premier industry forum dedicated to advancing next-generation immunodermatology therapies. With regulatory breakthroughs reshaping the landscape—such as Eli Lilly’s IL-13 inhibitor and LEO Pharma’s topical JAK-I—2024 was a pivotal year for the industry to accelerate innovation. Join 80+ senior leaders from Sanofi, Alys Pharmaceuticals, Moonlake Immunotherapeutics, and more to ensure 2025 breaks new records for the industry! Get stuck in to topics such as:
- Explore novel clinical and preclinical candidate data to produce best-in-class drugs for diverse indications
- Understand contemporary indication expansion strategies to maximise the value of your pipeline and diversify your immuno-inflammatory portfolio
- Collaborate with peers to accelerate trial timelines, optimize endpoint strategies, and enhance clinical data quality to fast track regulatory approval"
World-Class Speaker Faculty Include:
What Did Past Attendees Have to Say?
“The size and amount of participation at the summit made it perfect for networking and conference attendance.”
Sol-Gel Technologies
“The intimate and transparent atmosphere, the dedicated networking sessions, the relevance and quality of the presentations and the number of dermatology leaders attending were all great.“
Sanos Group
“I really enjoy how easy it is to network at the conference. I genuinely feel like each attendee welcomes being approached, and I made some valuable connections.”
Apogee Therapeutics
Our Partners:
